临床试验，第一阶段的临床试验
总计179个结果
-
Bayer完全的
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., Belgium完全的药代动力学 | 晚期恶性肿瘤 | 实体恶性肿瘤 | 蛋白激酶抑制剂 | 最大耐受剂量 | 抗肿瘤方案 | 临床试验，第一阶段
-
Instituto de Investigación Hospital Universitario...尚未招聘评估对早期临床试验招募平台的兴趣
-
Calliditas Therapeutics ABEurofins Optimed; York Bioanalytical Solution完全的
-
Daewoong Pharmaceutical Co. LTD.Shanghai Haini Pharmaceutical Co., Ltd.主动，不招人
-
Daewoong Pharmaceutical Co. LTD.完全的
-
Astellas Pharma Europe B.V.完全的
-
Universidade Estadual de Ponta GrossaCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.完全的
-
Handok Inc.CMG Pharmaceutical Co. Ltd完全的
-
Vanderbilt University Medical CenterNational Cancer Institute (NCI); Meharry-Vanderbilt Alliance完全的
-
Universidade Estadual de Ponta GrossaCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.完全的
-
University of Electronic Science and Technology...完全的Oxytocin Effect on Memory Performance During Phase 1 | Oxytocin Effect on Memory Performance During Phase 2 | Oxytocin Effect on Memory Performance During Phase 3 | Oxytocin Effect on Memory Performance During Phase 4中国
-
BeiGene招聘中1 期的局部晚期或转移性实体瘤、剂量递增和 2 期安全导入、HNSCC、NSCLC 和 RCC 参与者的 2 期澳大利亚, 西班牙, 法国, 意大利, 大韩民国, 波兰
-
University of Yaounde 1未知手术 | 麻醉 | 临床试验 | 妇科 | 阿片类药物喀麦隆
-
Women's College HospitalOttawa Hospital Research Institute; Cancer Care Ontario; Laval University; Ontario Institute for...完全的
-
Lone Graff StensballeHvidovre University Hospital; Kolding Sygehus; Danish National Research Foundation; Research Center...完全的
-
International Centre for Diarrhoeal Disease Research...Washington University School of Medicine招聘中
-
University of New MexicoNational Center for Research Resources (NCRR)终止
-
The Second Hospital of Nanjing Medical University完全的
-
Institut BergoniéInstitut National de la Santé Et de la Recherche Médicale, France主动，不招人
-
University of Texas Southwestern Medical CenterCancer Prevention Research Institute of Texas招聘中
-
Rutgers, The State University of New JerseyPfizer; American Cancer Society, Inc.完全的
-
Instituto Nacional de Cancerologia de Mexico完全的II期临床试验 | 96 例经组织学证实的 BM NSCLC 患者 | 随机 1:1 接受 TN 加 WBR 或仅接受 WBR | ICPFS 由两位盲法独立放射肿瘤学家通过 MRI 评估墨西哥